Novartis has renewed its memorandum of understanding with the World Health Organization (WHO) to lengthen its drug donation for Egaten® (triclabendazole) to 2022 and continues its war against liver fluke. WHO lists Egaten as the only medicine for fascioliasis and also includes it in the Model List of Essential Medicines.
System C has signed a contract to develop a collective child health information system in the South West of England. 708,000 child health records from South Gloucester, Bristol, Somerset and North Somerset, Devon, Torbay, Plymouth and Cornwall will be put to use by its CarePlus software.
Risk of Alzheimer's disease increases with reduction in levels of plasmalogens, a class of lipids produced by the liver that constitute cell membranes in the brain, confirms new research presented at the Alzheimer's Association International Conference (AAIC) 2018 by Mitchel A. Kling, MD, an associate professor of Psychiatry in the Perelman School of Medicine at the University of Pennsylvania and the Veterans Affairs Medical Center.
Biophysicists at Ruhr-Universität Bochum (RUB) have used an infrared sensor to discover which active agents influence the structure of proteins rapidly and easily and calculate the amount of time the change persists.
Cone beam imaging, a new stroke imaging technology was showcased at the Society of NeuroInterventional Surgery’s (SNIS) 15th Annual Meeting in a presented study which aims at preventing nearly an hour of delay in patient care, providing them with the prospect of complete recovery.
Healthy.io, of Israel, gains FDA 510(k) approval for Dip.io, it's domestic urinalysis kit that transforms a smartphone into a clinical-standard diagnostic machine. It is the first and only smartphone-based urine analysis to be cleared as a Class 2 device.
23andMe declared an investment of $300 million on Wednesday, made by GlaxoSmithKline to attain special access to their DNA database.
A 20 percent to 50 percent higher risk of developing endometriosis in women with a past of sexual or emotional abuse was observed by a European study published in the journal, Human Reproduction. Similarly, a large U.S. study in the same journal yielded matching results with sexual or physical abuse in the past.
Siemens Health received US-FDA (US-Food and Drug Administration) clearance for two highly sensitive troponin assays, which detect protein levels released into the bloodstream during a heart attack allowing them to be made available in the U.S.
On 26 July 2018, Omeros Corporation announced that the European Medicines Agency's (EMA's) Committee for Orphan Medicinal Products (COMP) have positively recommended the lead human monoclonal antibody named OMS721 for stem cell transplantation therapy.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.